Skip to main content

Diabetic Kidney Disease News

FDA Approves Invokana (canagliflozin) to Treat Diabetic Kidney Disease (DKD) and Reduce the Risk of Hospitalization for Heart Failure in Patients with Type 2 Diabetes and DKD

RARITAN, N.J., Sept. 30, 2019 /PRNewswire/ – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the U.S. Food and Drug Administration (FDA) approved a new indication for...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related drug support groups

lisinopril, losartan, ramipril, Invokana